tiprankstipranks
Trending News
More News >
Bonus Biogroup Ltd. (IL:BONS)
:BONS
Israel Market

Bonus Biogroup (BONS) Financial Statements

Compare
1 Followers

Bonus Biogroup Financial Overview

Bonus Biogroup's market cap is currently $246.43M. The company's EPS TTM is ; its P/E ratio is ―; Bonus Biogroup is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue 0.00 0.00 0.00 0.00 0.00
Gross Profit 0.00 -3.37M -4.10M -1.61M 0.00
Operating Income -29.79M -37.05M -64.73M -19.44M -20.91M
EBITDA -28.14M -35.60M -67.05M -18.39M -20.03M
Net Income -28.53M -38.70M -90.08M -22.02M -22.24M
Balance Sheet
Cash & Short-Term Investments 12.94M 53.62M 79.45M 16.09M 105.00K
Total Assets 44.89M 74.61M 104.32M 51.44M 6.99M
Total Debt 11.16M 11.95M 12.35M 5.15M 5.88M
Net Debt -1.78M -41.67M -67.10M -10.93M 5.77M
Total Liabilities 15.58M 18.22M 19.89M 20.75M 20.71M
Stockholders' Equity 29.30M 56.39M 84.43M 30.68M -13.72M
Cash Flow
Free Cash Flow -27.22M -35.20M -45.65M -16.00M -13.30M
Operating Cash Flow -26.40M -28.82M -39.84M -15.75M -13.11M
Investing Cash Flow -14.26M -6.29M -6.18M -254.00K -187.00K
Financing Cash Flow -1.16M 2.13M 113.42M 31.92M 4.92M
Currency in ILS

Bonus Biogroup Earnings and Revenue History

Bonus Biogroup Debt to Assets

Bonus Biogroup Cash Flow

Bonus Biogroup Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis